Sonoma Pharmaceuticals, Inc.
SNOA
$2.97
$0.051.71%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.37M | 5.24M | 4.08M | 2.59M | 3.13M |
| Total Receivables | 2.44M | 2.61M | 3.38M | 3.48M | 3.16M |
| Inventory | 2.92M | 3.14M | 2.84M | 2.66M | 2.72M |
| Prepaid Expenses | 1.92M | 1.39M | 1.93M | 3.20M | 3.54M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 12.65M | 12.38M | 12.22M | 11.93M | 12.55M |
|
|
|||||
| Total Current Assets | 12.65M | 12.38M | 12.22M | 11.93M | 12.55M |
| Net Property, Plant & Equipment | 309.00K | 334.00K | 417.00K | 518.00K | 651.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 736.00K | 954.00K | 1.05M | 1.23M | 1.54M |
| Total Assets | 13.69M | 13.67M | 13.69M | 13.67M | 14.74M |
|
|
|||||
| Total Accounts Payable | 953.00K | 1.40M | 770.00K | 751.00K | 607.00K |
| Total Accrued Expenses | 1.74M | 1.92M | 2.02M | 2.23M | 1.42M |
| Short-term Debt | 220.00K | -- | 82.00K | 204.00K | 323.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 58.00K | 90.00K | 116.00K | 155.00K | 198.00K |
| Total Finance Division Other Current Liabilities | 1.13M | 302.00K | 319.00K | 413.00K | 1.17M |
| Total Other Current Liabilities | 1.13M | 302.00K | 319.00K | 413.00K | 1.17M |
| Total Current Liabilities | 4.10M | 3.70M | 3.31M | 3.75M | 3.72M |
|
|
|||||
| Total Current Liabilities | 4.10M | 3.70M | 3.31M | 3.75M | 3.72M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 220.00K | -- | 82.00K | 204.00K | 323.00K |
| Capital Leases | 27.00K | 29.00K | 46.00K | 61.00K | 87.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.16M | 5.07M | 4.98M | 4.89M | 4.80M |
| Total Liabilities | 9.28M | 8.80M | 8.33M | 8.70M | 8.60M |
|
|
|||||
| Common Stock & APIC | 206.59M | 206.45M | 205.65M | 204.07M | 203.21M |
| Retained Earnings | -197.81M | -197.03M | -196.10M | -195.49M | -194.35M |
| Treasury Stock & Other | -4.38M | -4.55M | -4.20M | -3.60M | -2.72M |
| Total Common Equity | 4.41M | 4.87M | 5.35M | 4.98M | 6.14M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.41M | 4.87M | 5.35M | 4.98M | 6.14M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.41M | 4.87M | 5.35M | 4.98M | 6.14M |
|
|
|||||